Bedaquiline in the multidrug-resistant tuberculosis treatment: Belarus experience

Conclusion Our interim results on safety and effectiveness of bedaquiline-containing regimens in multidrug and extensively drug-resistant tuberculosis (M/XDR-TB) patients are encouraging. They will add value to understanding role and place of this new anti-TB drug in M/XDR-TB treatment.
Source: International Journal of Mycobacteriology - Category: Infectious Diseases Source Type: research